3.89 USD
↘ 0.21 (5.12%)AT CLOSE (11:59 AM EDT)
Mannkind Corporation
MNKDNASDAQ • USD
3.85
↘ 0.04 (0.93%)
POST MARKET (AS OF 07:55 PM EDT)
Post Market
AS OF 07:55 PM EDT
3.85
↘ 0.04 (0.93%)
Market: CLOSED
Mannkind Corporation (MNKD) trades at $3.89 per share. Both sides of the analysis point lower: technicals flash "Strong Sell" and fundamentals confirm with a "Sell" reading. Notable factors include a concerning Altman Z-Score in the distress zone, a weak Piotroski F-Score of 2/9, exceptional Return on Equity (64.9%) and a bearish Death Cross on the long-term moving averages. Valuation metrics place MNKD at a fair price relative to peers.
Technical & fundamental data as of Aug 6, 2026.
Open?$3.82
High?$3.93
Low?$3.69
Prev. Close?$4.10
Volume?9.3M
Avg. Volume?5.0M
VWAP?$3.83
Rel. Volume?1.86x
Bid / Ask
Bid?$3.32 × 100
Ask?$3.91 × 100
Spread?$0.59
Midpoint?$3.62
Valuation & Ratios
Market Cap?1.3B
Shares Out?309.0M
Float?277.4M
Float %?89.8%
P/E Ratio?N/A
P/B Ratio?-19.49
EPS?-$0.14
Dividend?0.00%
Ex-Dividend?N/A
News
Profile
MannKind Corp is a biopharmaceutical company focused on the development and commercialization of patient-centric therapies that address serious unmet medical needs for those living with cardiometabolic and orphan lung diseases. The Company is currently commercializing three products: Afrezza (insulin human) Inhalation Powder, an ultra rapid-acting inhaled insulin indicated to improve glycemic control in adults with diabetes; Furoscix (furosemide injection), to treat fluid buildup in patients with chronic heart failure or chronic kidney disease; and the V-Go wearable insulin delivery device, which provides continuous subcutaneous infusion of insulin in adults that require insulin.
Employees
592
Market Cap
1.3B
Industry
PHARMACEUTICAL PREPARATIONS
Website
Listed
2004-07-28
Address
1 CASPER STREET
DANBURY, CT 06810
Phone: 818-661-5000
DANBURY, CT 06810
Phone: 818-661-5000
Technical OutlookStrong Sell
Strong SellNeutralStrong Buy
Long-Term (Tide)?▼ Bearish(-2/3)
Medium-Term (Wave)?▼ Bearish(-3/3)
Short-Term (Ripple)?▼ Bearish(-3/3)
MA Alignment?Mixed
Full Technical Analysis →Fundamental OutlookSell
Strong SellNeutralStrong Buy
F-Score?12
Z-Score?0
Momentum?55
Short Sent.?55
Piotroski F-Score?2/9Weak
Altman Z-Score?-4.46Distress
Confidence?61%Moderate
Short InterestHigh
Short % of Float?10.16%High
Short Interest?28.2M
Days to Cover?5.9
Free Float277.4M
Avg Daily Volume4.8M
Settlement Date2026-07-15
Financial Health
Current Ratio?1.72Adequate
Quick Ratio?1.41Adequate
Cash Ratio?0.37Low
Debt/Equity?-7.22Low
ValuationFAIRLY VALUEDvs 1 peers + S&P 500
Score67/100
P/E?N/A▾
P/B?-19.49CHEAP▾
S&P97
P/S?3.33FAIR▾
Peers100
S&P46
P/FCF?N/A▾
EV/EBITDA?61.9HIGH▾
Peers100
S&P3
EV/Sales?4.42FAIR▾
Peers100
S&P41
Returns & Efficiency
ROE?64.9%STRONG▾
Peers50
S&P93
ROA?-6.0%WEAK▾
S&P3
Cash Flow & Enterprise
FCF?$-18135000
Enterprise Value?$1.7B
Fundamentals ratios updated end of day